JATT compared with ENTA: revenue, margins and what each company keeps, and the suppliers and customers both name

JATTJATT II Acquisition Corp.

Mkt capRevenueRevenue

ENTAEnanta Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

JATTJATT II Acquisition Corp.

ENTAEnanta Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

JATT

No earnings history for JATT.

ENTA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±19.1%▼−2.10%×0.11

Q2 FY26±19.0%▼−6.02%×0.32

Q1 FY26±13.1%▲+2.17%×0.17

Nov 18 '25±17.1%▼−3.59%×0.21

= impliedJATT realized, solidENTA realized, hatchedOne scale, both sides: full bar = 20%× = |realized| ÷ impliedSource: market data

JATTJATT II Acquisition Corp.

10.25· pre 10.25· delayed

Mkt cap$65.8MRevenue—Revenue—

ENTAEnanta Pharmaceuticals Inc

10.48· pre 10.47· delayed

Pre-marketNov 2 '26delayed

Mkt cap$303.8MRevenue$14MQ3 FY26Revenue$67MFY24

Compare

Pre-marketNov 2 '26delayed

JATTJATT II Acquisition Corp.

ENTAEnanta Pharmaceuticals Inc

10.25pre 10.25delayed

Price

10.48pre 10.47delayed

$65.8M

Mkt cap

$303.8M

—

Revenue

$14MQ3 FY26

—

Revenue

$67MFY24

JATT10.25vsENTA10.48Pre-marketNov 2 '26delayed